News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,640 Results
Type
Article (44941)
Company Profile (323)
Press Release (692359)
Multimedia
Podcasts (119)
Webinars (19)
Section
Business (212658)
Career Advice (2192)
Deals (37157)
Drug Delivery (119)
Drug Development (84426)
Employer Resources (177)
FDA (16849)
Job Trends (15639)
News (360680)
Policy (34588)
Tag
Academia (2635)
Accelerated approval (15)
Adcomms (32)
Allergies (115)
Alliances (52223)
ALS (132)
Alzheimer's disease (1556)
Antibody-drug conjugate (ADC) (192)
Approvals (16884)
Artificial intelligence (386)
Autoimmune disease (45)
Automation (23)
Bankruptcy (378)
Best Places to Work (11842)
BIOSECURE Act (21)
Biosimilars (145)
Biotechnology (193)
Bladder cancer (112)
Brain cancer (43)
Breast cancer (420)
Cancer (3409)
Cardiovascular disease (295)
Career advice (1835)
Career pathing (35)
CAR-T (212)
CDC (42)
Cell therapy (567)
Cervical cancer (27)
Clinical research (69996)
Collaboration (1241)
Company closure (4)
Compensation (855)
Complete response letters (47)
COVID-19 (2757)
CRISPR (75)
C-suite (491)
Cystic fibrosis (124)
Data (3759)
Decentralized trials (2)
Denatured (35)
Depression (89)
Diabetes (408)
Diagnostics (6606)
Digital health (27)
Diversity (11)
Diversity, equity & inclusion (46)
Drug discovery (174)
Drug pricing (162)
Drug shortages (34)
Duchenne muscular dystrophy (176)
Earnings (90715)
Editorial (48)
Employer branding (21)
Employer resources (154)
Events (118794)
Executive appointments (920)
FDA (19033)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1074)
Gene editing (159)
Generative AI (31)
Gene therapy (457)
GLP-1 (942)
Government (4785)
Grass and pollen (6)
Guidances (333)
Healthcare (19186)
HIV (43)
Huntington's disease (33)
IgA nephropathy (51)
Immunology and inflammation (207)
Immuno-oncology (15)
Indications (46)
Infectious disease (2962)
Inflammatory bowel disease (168)
Inflation Reduction Act (10)
Influenza (77)
Intellectual property (164)
Interviews (343)
IPO (17048)
IRA (56)
Job creations (4172)
Job search strategy (1557)
Kidney cancer (14)
Labor market (64)
Layoffs (574)
Leadership (29)
Legal (8561)
Liver cancer (84)
Longevity (12)
Lung cancer (492)
Lymphoma (247)
Machine learning (22)
Management (61)
Manufacturing (543)
MASH (116)
Medical device (13695)
Medtech (13712)
Mergers & acquisitions (20925)
Metabolic disorders (1040)
Multiple sclerosis (116)
NASH (20)
Neurodegenerative disease (169)
Neuropsychiatric disorders (45)
Neuroscience (2416)
NextGen: Class of 2025 (6731)
Non-profit (4569)
Now hiring (53)
Obesity (523)
Opinion (276)
Ovarian cancer (112)
Pain (155)
Pancreatic cancer (142)
Parkinson's disease (207)
Partnered (24)
Patents (377)
Patient recruitment (265)
Peanut (56)
People (60556)
Pharmaceutical (98)
Pharmacy benefit managers (25)
Phase I (21790)
Phase II (30754)
Phase III (23011)
Pipeline (2442)
Policy (260)
Postmarket research (2687)
Preclinical (9237)
Press Release (68)
Prostate cancer (168)
Psychedelics (41)
Radiopharmaceuticals (265)
Rare diseases (563)
Real estate (6387)
Recruiting (68)
Regulatory (24366)
Reports (51)
Research institute (2408)
Resumes & cover letters (371)
Rett syndrome (11)
RNA editing (13)
RSV (62)
Schizophrenia (117)
Series A (178)
Series B (134)
Service/supplier (14)
Sickle cell disease (72)
Special edition (24)
Spinal muscular atrophy (154)
Sponsored (35)
Startups (3815)
State (2)
Stomach cancer (16)
Supply chain (93)
Tariffs (83)
The Weekly (82)
Vaccines (907)
Venture capital (60)
Weight loss (358)
Women's health (52)
Worklife (18)
Date
Today (132)
Last 7 days (470)
Last 30 days (2314)
Last 365 days (31723)
2025 (22330)
2024 (36148)
2023 (40930)
2022 (52114)
2021 (56674)
2020 (55108)
2019 (47821)
2018 (36139)
2017 (33569)
2016 (33170)
2015 (39008)
2014 (32961)
2013 (28077)
2012 (30166)
2011 (30871)
2010 (28889)
Location
Africa (816)
Alabama (70)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (42368)
Australia (6714)
California (8634)
Canada (2673)
China (816)
Colorado (363)
Connecticut (369)
Delaware (231)
Europe (91087)
Florida (1300)
Georgia (287)
Hawaii (2)
Idaho (60)
Illinois (701)
India (41)
Indiana (419)
Iowa (17)
Japan (269)
Kansas (116)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1155)
Massachusetts (6362)
Michigan (268)
Minnesota (509)
Mississippi (4)
Missouri (101)
Montana (28)
Nebraska (25)
Nevada (101)
New Hampshire (68)
New Jersey (2375)
New Mexico (31)
New York (2345)
North Carolina (1253)
North Dakota (8)
Northern California (3900)
Ohio (265)
Oklahoma (18)
Oregon (41)
Pennsylvania (1822)
Puerto Rico (18)
Rhode Island (41)
South America (1187)
South Carolina (44)
South Dakota (1)
Southern California (3313)
Tennessee (139)
Texas (1338)
United States (31626)
Utah (258)
Virginia (223)
Washington D.C. (76)
Washington State (721)
West Virginia (4)
Wisconsin (75)
737,640 Results for "cocrystal pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 15, 2025
·
4 min read
Press Releases
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 16, 2025
·
3 min read
Press Releases
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference
September 4, 2025
·
1 min read
Press Releases
Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference
September 15, 2025
·
5 min read
Press Releases
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
September 9, 2025
·
4 min read
Press Releases
Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
August 15, 2025
·
13 min read
Press Releases
Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference
August 6, 2025
·
7 min read
Press Releases
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
June 5, 2025
·
5 min read
Press Releases
Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
May 28, 2025
·
1 min read
Press Releases
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
April 16, 2025
·
1 min read
1 of 73,764
Next
